Symbol |
Name |
ACHE
|
acetylcholinesterase (Yt blood group)
|
ALPI
|
alkaline phosphatase, intestinal
|
ALPL
|
alkaline phosphatase, liver/bone/kidney
|
ALPP
|
alkaline phosphatase, placental
|
ALPPL2
|
alkaline phosphatase, placental-like 2
|
ART1
|
ADP-ribosyltransferase 1
|
ART3
|
ADP-ribosyltransferase 3
|
ART4
|
ADP-ribosyltransferase 4 (Dombrock blood group)
|
BCAN
|
brevican
|
BST1
|
bone marrow stromal cell antigen 1
|
BST2
|
bone marrow stromal cell antigen 2
|
CA4
|
carbonic anhydrase IV
|
CD109
|
CD109 molecule
|
CD14
|
CD14 molecule
|
CD160
|
CD160 molecule
|
CD177
|
CD177 molecule
|
CD2
|
CD2 molecule
|
CD24
|
CD24 molecule
|
CD48
|
CD48 molecule
|
CD52
|
CD52 molecule
|
CD55
|
CD55 molecule, decay accelerating factor for complement (Cromer blood group)
|
CD58
|
CD58 molecule
|
CD59
|
CD59 molecule, complement regulatory protein
|
CDH13
|
cadherin 13
|
CEACAM5
|
carcinoembryonic antigen-related cell adhesion molecule 5
|
CEACAM6
|
carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen)
|
CEACAM7
|
carcinoembryonic antigen-related cell adhesion molecule 7
|
CEACAM8
|
carcinoembryonic antigen-related cell adhesion molecule 8
|
CFC1
|
cripto, FRL-1, cryptic family 1
|
CNTFR
|
ciliary neurotrophic factor receptor
|
CNTN1
|
contactin 1
|
CNTN2
|
contactin 2 (axonal)
|
CNTN3
|
contactin 3 (plasmacytoma associated)
|
CNTN4
|
contactin 4
|
CNTN5
|
contactin 5
|
CNTN6
|
contactin 6
|
CPM
|
carboxypeptidase M
|
DPEP1
|
dipeptidase 1 (renal)
|
DPEP2
|
dipeptidase 2
|
DPEP3
|
dipeptidase 3
|
EFNA1
|
ephrin-A1
|
EFNA2
|
ephrin-A2
|
EFNA3
|
ephrin-A3
|
EFNA4
|
ephrin-A4
|
EFNA5
|
ephrin-A5
|
ENPP6
|
ectonucleotide pyrophosphatase/phosphodiesterase 6
|
FCGR3B
|
Fc fragment of IgG, low affinity IIIb, receptor (CD16b)
|
FOLR1
|
folate receptor 1 (adult)
|
FOLR2
|
folate receptor 2 (fetal)
|
GAD2
|
glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa)
|
GAS1
|
growth arrest-specific 1
|
GFRA1
|
GDNF family receptor alpha 1
|
GFRA2
|
GDNF family receptor alpha 2
|
GFRA3
|
GDNF family receptor alpha 3
|
GFRA4
|
GDNF family receptor alpha 4
|
GGT1
|
gamma-glutamyltransferase 1
|
GGT5
|
gamma-glutamyltransferase 5
|
GGT6
|
gamma-glutamyltransferase 6
|
GGT7
|
gamma-glutamyltransferase 7
|
GGTLC1
|
gamma-glutamyltransferase light chain 1
|
GGTLC2
|
gamma-glutamyltransferase light chain 2
|
GML
|
glycosylphosphatidylinositol anchored molecule like
|
GP1BA
|
glycoprotein Ib (platelet), alpha polypeptide
|
GP2
|
glycoprotein 2 (zymogen granule membrane)
|
GPC1
|
glypican 1
|
GPC2
|
glypican 2
|
GPC3
|
glypican 3
|
GPC4
|
glypican 4
|
GPC5
|
glypican 5
|
GPC6
|
glypican 6
|
GPIHBP1
|
glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1
|
HFE2
|
hemochromatosis type 2 (juvenile)
|
HYAL2
|
hyaluronoglucosaminidase 2
|
ITLN1
|
intelectin 1 (galactofuranose binding)
|
IZUMO1R
|
IZUMO1 receptor, JUNO
|
LPL
|
lipoprotein lipase
|
LSAMP
|
limbic system-associated membrane protein
|
LY6D
|
lymphocyte antigen 6 complex, locus D
|
LY6E
|
lymphocyte antigen 6 complex, locus E
|
LY6G6C
|
lymphocyte antigen 6 complex, locus G6C
|
LY6G6D
|
lymphocyte antigen 6 complex, locus G6D
|
LY6H
|
lymphocyte antigen 6 complex, locus H
|
LY6K
|
lymphocyte antigen 6 complex, locus K
|
LYNX1
|
Ly6/neurotoxin 1
|
LYPD1
|
LY6/PLAUR domain containing 1
|
LYPD2
|
LY6/PLAUR domain containing 2
|
LYPD3
|
LY6/PLAUR domain containing 3
|
LYPD4
|
LY6/PLAUR domain containing 4
|
LYPD5
|
LY6/PLAUR domain containing 5
|
LYPD6B
|
LY6/PLAUR domain containing 6B
|
LYPD8
|
LY6/PLAUR domain containing 8
|
MDGA1
|
MAM domain containing glycosylphosphatidylinositol anchor 1
|
MDGA2
|
MAM domain containing glycosylphosphatidylinositol anchor 2
|
MFI2
|
antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5
|
MMP17
|
matrix metallopeptidase 17 (membrane-inserted)
|
MMP25
|
matrix metallopeptidase 25
|
MSLN
|
mesothelin
|
NCAM1
|
neural cell adhesion molecule 1
|
NEGR1
|
neuronal growth regulator 1
|
NRN1
|
neuritin 1
|
NRN1L
|
neuritin 1-like
|
NT5E
|
5'-nucleotidase, ecto (CD73)
|
NTM
|
neurotrimin
|
NTNG1
|
netrin G1
|
NTNG2
|
netrin G2
|
OMG
|
oligodendrocyte myelin glycoprotein
|
OPCML
|
opioid binding protein/cell adhesion molecule-like
|
OTOA
|
otoancorin
|
PKHD1
|
polycystic kidney and hepatic disease 1 (autosomal recessive)
|
PLAUR
|
plasminogen activator, urokinase receptor
|
PLET1
|
placenta expressed transcript 1
|
PRND
|
prion protein 2 (dublet)
|
PRNP
|
prion protein
|
PRSS21
|
protease, serine, 21 (testisin)
|
PRSS41
|
protease, serine, 41
|
PRSS42
|
protease, serine, 42
|
RAET1G
|
retinoic acid early transcript 1G
|
RAET1L
|
retinoic acid early transcript 1L
|
RECK
|
reversion-inducing-cysteine-rich protein with kazal motifs
|
RGMA
|
repulsive guidance molecule family member a
|
RGMB
|
repulsive guidance molecule family member b
|
RHBG
|
Rh family, B glycoprotein (gene/pseudogene)
|
RTN4R
|
reticulon 4 receptor
|
RTN4RL1
|
reticulon 4 receptor-like 1
|
RTN4RL2
|
reticulon 4 receptor-like 2
|
SEMA7A
|
semaphorin 7A, GPI membrane anchor (John Milton Hagen blood group)
|
SPACA4
|
sperm acrosome associated 4
|
SPAM1
|
sperm adhesion molecule 1 (PH-20 hyaluronidase, zona pellucida binding)
|
SPRN
|
shadow of prion protein homolog (zebrafish)
|
TDGF1
|
teratocarcinoma-derived growth factor 1
|
TECTA
|
tectorin alpha
|
TECTB
|
tectorin beta
|
TEX101
|
testis expressed 101
|
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
|
THY1
|
Thy-1 cell surface antigen
|
TNFRSF10C
|
tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain
|
TREH
|
trehalase (brush-border membrane glycoprotein)
|
ULBP1
|
UL16 binding protein 1
|
ULBP2
|
UL16 binding protein 2
|
ULBP3
|
UL16 binding protein 3
|
UMOD
|
uromodulin
|
VNN1
|
vanin 1
|
VNN2
|
vanin 2
|
VNN3
|
vanin 3
|
XPNPEP2
|
X-prolyl aminopeptidase (aminopeptidase P) 2, membrane-bound
|